# Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache

> **NCT00311662** · PHASE2 · COMPLETED · sponsor: **Minster Research Ltd** · enrollment: 124 (actual)

## Conditions studied

- Migraine Without Aura
- Migraine With Aura

## Interventions

- **DRUG:** Tonabersat
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00311662
- **Lead sponsor:** Minster Research Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2009-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00311662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00311662, "Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00311662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*